99 Publications (Page 3 of 4)
2008
Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.
Shiozawa, YusukeHavens, Aaron MJung, YounghunZiegler, Anne MPedersen, Elisabeth AWang, J.Wang, JingchengWang, JianhuaLu, GanweiRoodman, G DLoberg, Robert DPienta, Kenneth J and Taichman, Russell S
Journal of cellular biochemistry, vol. 105, (no. 2), pp. 370-80, 2008/Oct/1. | Journal Article
 
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma, YukoKurihara, NoriyoshiSubler, Mark AZhou, HuaBoykin, Christina SZhang, HejuIshizuka, SeiichiDempster, David WRoodman, G. D and Windle, Jolene J
Human molecular genetics, vol. 17, (no. 23), pp. 3708-19, 2008/Dec/1. | Journal Article
2007
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease
Kurihara, NoriyoshiKurihara, NoriyoshiHiruma, YukoHiruma, YukoZhou, HuaZhou, HuaSubler, Mark ASubler, Mark ADempster, David WDempster, David WSinger, Frederick RSinger, Frederick RReddy, SakamuriReddy, Sakamuri VGruber, HelenGruber, Helen EWindle, Jolene JWindle, Jolene JRoodman, G David and Roodman, G David
Journal of Clinical Investigation, vol. 117, (no. 1), pp. 133-142, 2007. | Journal Article
 
Pathophysiology of myeloma bone disease.
Esteve, Flavia R and Roodman, G David
Best practice & research. Clinical haematology, vol. 20, (no. 4), pp. 613-624, December 2007. | Journal Article
 
Treatment strategies for bone disease
Roodman, G. D
Bone Marrow Transplantation, vol. 40, (no. 12), pp. 1139-1146, 2007. | Journal Article
2006
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
Lipton, A.Lipton, AllanBerenson, J.R.Berenson, James RBody, J.-J.Body, Jean-JacquesBoyce, B.F.Boyce, Brendan FBruland, O.S.Bruland, øyvind SCarducci, Michael ACarducci, M.A.Cleeland, Charles SCleeland, C.S.Clohisy, Denis RClohisy, D.R.Coleman, R.E.Coleman, Robert ECook, Richard JCook, R.J.Guise, T.A.Guise, Theresa APearse, RogerPearse, R.N.Powles, Trevor JPowles, T.J.Rogers, M.J.Rogers, Michael JRoodman, G DavidRoodman, G.D.Smith, Matthew RSmith, M.R.Suva, Larry JSuva, L.J.Vessella, Robert LVessella, R.L.Weilbaecher, K.N.Weilbaecher, Katherine NKing, L. and King, Laura
Clinical Cancer Research, vol. 12, (no. 20), pp. 6209s-6212s, 2006. | Journal Article
 
Chemokines in multiple myeloma.
Aggarwal, RohitGhobrial, Irene M and Roodman, G David
Experimental hematology, vol. 34, (no. 10), pp. 1289-1295, October 2006. | Journal Article
 
Experimental Models of Paget's Disease
Kurihara, NoriyoshiZhou, H.Reddy, SVPalacios, VGGarcia Palacios, VeronicaSubler, MADempster, DWWindle, Jolene J and Roodman, G. D
Journal of Bone and Mineral Research, vol. 21, pp. p. P55, 2006. | Journal Article
2005
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Ishizuka, SeiichiKurihara, NoriyoshiReddy, Sakamuri VCornish, JillianCundy, Tim and Roodman, G David
Endocrinology, vol. 146, (no. 4), pp. 2023-2030, April 2005. | Journal Article
2004
Mechanisms of Bone Metastasis
Roodman, G David
The New England Journal of Medicine, vol. 350, (no. 16), pp. 1655-64, Apr 15, 2004. | Journal Article
2002
Multiple myeloma.
Anderson, Kenneth CShaughnessy, John DBarlogie, BartHarousseau, Jean-Luc and Roodman, G David
Hematology. American Society of Hematology. Education Program, pp. 214-240, 2002. | Journal Article
2001
ADAM8: a novel osteoclast stimulating factor.
Choi, S JHan, J H and Roodman, G D
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 16, (no. 5), pp. 814-822, May 2001. | Journal Article
 
Antisense inhibition of macrophage inflammatory protein 1- alpha blocks bone destruction in a model of myeloma bone disease
Choi, SJOba, Y.Gazitt, YairAlsina, M.Cruz, J.Anderson, J. and Roodman, Gd
Journal of Clinical Investigation, vol. 108, (no. 12), pp. 1833-1841, 2001. | Journal Article
 
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Cruz, J CAlsina, MCraig, FYoneda, TAnderson, J LDallas, M and Roodman, G D
Experimental hematology, vol. 29, (no. 4), pp. 441-447, April 2001. | Journal Article
 
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment.
Choi, S JKurihara, NOba, Y and Roodman, G D
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 16, (no. 10), pp. 1804-1811, October 2001. | Journal Article
 
Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts.
Reddy, S VKurihara, NMenaa, CLanducci, GForthal, Donald NKoop, B AWindle, J J and Roodman, G D
Endocrinology, vol. 142, (no. 7), pp. 2898-905, 2001/Jul. | Journal Article
 
Paget's Disease of Bone: A Disease of the Osteoclast
Kurihara, NoriyoshiMenaa, Cheikh and Roodman, G
Reviews in Endocrine & Metabolic Disorders, vol. 2, (no. 2), pp. 195-201, Apr 2001. | Journal Article
2000
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa, CheikhMenaa, CReddy, Sakamuri VReddy, S VKurihara, NoriyoshiKurihara, NMaeda, HMaeda, HidefumiAnderson, DirkAnderson, DCundy, TCundy, TimCornish, JCornish, JillianSinger, F RSinger, Frederick RBruder, J MBruder, Jan MRoodman, G D and Roodman, G. David
The Journal of clinical investigation, vol. 105, (no. 12), pp. 1833-1838, June 2000. | Journal Article
 
Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease.
Whyte, Michael PMills, B GReinus, William RPodgornik, M NRoodman, G DGannon, F HEddy, M C and Mc Alister, William H
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 15, (no. 12), pp. 2330-44, 2000/Dec. | Journal Article
 
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
Kurihara, NReddy, S VMenaa, CAnderson, D and Roodman, G D
The Journal of clinical investigation, vol. 105, (no. 5), pp. 607-614, March 2000. | Journal Article
1999
Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures.
Menaa, CDevlin, R DReddy, S VGazitt, YChoi, S J and Roodman, G D
The Journal of clinical investigation, vol. 103, (no. 11), pp. 1605-1613, June 1999. | Journal Article
 
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.
Halleen, J MRäisänen, SSalo, J JReddy, S VRoodman, G DHentunen, T ALehenkari, P PKaija, HVihko, P and Väänänen, H K
The Journal of biological chemistry, vol. 274, (no. 33), pp. 22907-22910, August 13, 1999. | Journal Article
 
Mechanisms of abnormal bone turnover in Paget's disease.
Roodman, G D
Bone, vol. 24, (no. 5 Suppl), pp. 39S-40S, May 1999. | Journal Article
1998
Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
Choi, S JDevlin, R DMenaa, CChung, HRoodman, G D and Reddy, S V
The Journal of clinical investigation, vol. 102, (no. 7), pp. 1360-1368, October 1, 1998. | Journal Article
 
Epitope mapping of recombinant human procathepsin D.
Sachdev, DeepaliOhsaki, YRoodman, G D and Chirgwin, J M
Advances in experimental medicine and biology, vol. 436, pp. 185-9, 1998. | Journal Article